Gilead Sciences
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Gilead Sciences is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Gilead Sciences embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of Gilead Sciences
Daniel P. O'Day
Summary:
Headquartered in Foster City, California, Gilead Sciences is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Daniel P. O'Day serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $304,450 to Republican causes and $1,983,265 to Democratic causes. Under their tenure, Gilead Sciences currently holds a 'High Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$304,450
$1,983,265
Republican
Democrat
Shareholder Proposals
Expand Summary
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 5/8/24 | John Chevedden | Executives to Retain Significant Stock | Against | N/A | |
| 5/8/24 | Jing Zhao | Adopt a Policy to Include Non-Management Employee as Director Candidates | Against | N/A | |
| 5/8/24 | Bowyer Research on behalf of David Bahnsen | Report on Risks of supporting Abortion | Against | N/A | |
| 5/3/23 | Social | Adrian Dominican Sisters | Report on Impact of Extended Patent Exclusivities on Product Access | Against | 16.50% |
| 5/3/23 | Governance | John Chevedden | Special Shareholder Meeting Improvement | Against | 4.60% |
| 5/3/23 | Governance | Jing Zhao | Nominate More Candidates than there are Directors | Against | 0.70% |
| 5/4/22 | Governance | John Chevedden | Special Meetings - Reduce Ownership Req. to 10% | Against | 56.66% |
| 5/4/22 | Social | Maryknoll Sisters of St. Dominic | 3rd Party Review of Alignment of Lobbying with its Public Statements | Against | 49.88% |
| 5/4/22 | Governance | United Church Funds | Require Independent Board Chair | Against | 40.33% |
| 5/4/22 | Governance | Mercy Investment Services | Report on Board Oversight of Risks Related to Anticompetitive Practices | Against | 39.27% |
| 5/4/22 | Governance | Jing Zhao | Adopt a Policy to Include Non-Management Employee as Director Candidates | Against | 6.67% |